MiR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia

Molecular Biology Reports

Volumn 39, Issue 3, 2012, Pages 2713-2722

  Wang, Fang ^a   Wang, Xiao Shuang ^a   Yang, Gui Hua ^a   Zhai, Peng Fei ^a   Xiao, Zhen ^a,b   Xia, Liang Yu ^c   Chen, Li Rong ^d   Wang, Yu ^e   Wang, Xiao Zhong ^f   Bi, Lai Xi ^g   Liu, Nian ^h   Yu, Yang ⁱ   Gao, Da ^b   Huang, Bin Tao ^b   Wang, Jing ^b   Zhou, Dao Bin ^b   Gong, Jia Nan ^b   Zhao, Hua Lu ^b   Bi, Xiu Hua ^b   Yu, Jia ^c   Zhang, Jun Wu ^a   more..

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b INNER MONGOLIA MEDICAL COLLEGE   (China)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^d THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIVERSITY   (China)

^e XINXIANG CENTRAL HOSPITAL   (China)

^f NANCHANG UNIVERSITY   (China)

^g WENZHOU MEDICAL UNIVERSITY   (China)

^h CHINESE PLA GENERAL HOSPITAL   (China)

ⁱ CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia (AML); Expression profile; MicroRNAs (miRNAs); miR 142 3p; miR 29a

Indexed keywords

MICRORNA; MICRORNA 142 3P; MICRORNA 29A; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NORTHERN BLOTTING; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY;

AREA UNDER CURVE; BLOTTING, NORTHERN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTES, MONONUCLEAR; MICROARRAY ANALYSIS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84861517382     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1026-5     Document Type: Article

References (48)

1. Frankfurt O, Licht JD, Tallman MS (2007) Molecular characterization of acute myeloid leukemia and its impact on treatment. Curr Opin Oncol 19:635-649
2. Haferlach T, Bacher U, Haferlach C, Kern W, Schnittger S (2007) Insight into the molecular pathogenesis of myeloid malignancies. Curr Opin Hematol 14:90-97
3. Chang TC, Mendell JT (2007) MicroRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 8:215-239
4. Stefani G (2007) Roles of microRNAs and their targets in cancer. Expert Opin Biol Ther 7:1833-1840
5. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102:13944-13949
6. Marton S, Garcia MR, Robello C, Persson H, Trajtenberg F, Pritsch O et al (2008) Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia 22:330-338
7. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH (2010) Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10:42-46
8. Iorio MV, Casalini P, Tagliabue E, Menard S, Croce CM (2008) MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. Eur J Cancer 44:2753-2759
9. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE (2009) The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 112:55-59
10. Osaki M, Takeshita F, Ochiya T (2008) MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers 13:658-670
11. Marcucci G, Radmacher MD, Maharry K, Mrozek K, Ruppert AS, Paschka P et al (2008) MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 358: 1919-1928
12. Whitman SP, Maharry K, Radmacher MD, Becker H, Mrozek K, Margeson D et al (2010) FLT3 internal tandem duplication associates with adverse outcome and gene-and microRNAexpression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood. doi:10.1182/blood-2010-05-283648
13. Jongen-Lavrencic M, Sun SM, Dijkstra MK, Valk PJ, Lowenberg B (2008) MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 111:5078-5085
14. Debernardi S, Skoulakis S, Molloy G, Chaplin T, Dixon-McIver A, Young BD (2007) MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 21:912-916
15. Dixon-McIver A, East P, Mein CA, Cazier JB, Molloy G, Chaplin T et al (2008) Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukemia. PLoS ONE 3:e2141
16. Blum W, Garzon R, Klisovic RB, Schwind S, Walker A, Geyer S et al (2010) Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine. Proc Natl Acad Sci USA 107:7473-7478
17. Liu S, Wu LC, Pang J, Santhanam R, Schwind S, Wu YZ et al (2010) Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell 17:333-347
18. Pulikkan JA, Dengler V, Peramangalam PS, Peer Zada AA, Muller-Tidow C, Bohlander SK et al (2010) Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 115:1768-1778
19. Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C et al (2008) Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 105:3945-3950
20. Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86
21. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT et al (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33:e179
22. Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL et al (2008) HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 358:353-361
23. Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, Jia WH, Zhuang SM (2010) Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51:836-845
24. Rasmussen KD, Simmini S, Abreu-Goodger C, Bartonicek N, Di Giacomo M, Bilbao-Cortes D et al (2010) The miR-144/451 locus is required for erythroid homeostasis. J Exp Med 207:1351-1358
25. Merkerova M, Belickova M, Bruchova H (2008) Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol 381:304-310
26. Choong ML, Yang HH, McNiece I (2007) MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp Hematol 35:551-564
27. Isken F, Steffen B, Merk S, Dugas M, Markus B, Tidow N et al (2008) Identification of acute myeloid leukaemia associated microRNA expression patterns. Br J Haematol 140:153-161
28. Georgantas RW 3rd, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S et al (2007) CD34? hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA 104:2750-2755
29. le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A et al (2007) Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26:3699-3708
30. Myatt SS, Wang J, Monteiro LJ, Christian M, Ho KK, Fusi L et al (2010) Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res 70:367-377
31. Popovic R, Riesbeck LE, Velu CS, Chaubey A, Zhang J, Achille NJ et al (2009) Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 113:3314-3322
32. Garzon R, Pichiorri F, Palumbo T, Iuliano R, Cimmino A, Aqeilan R et al (2006) MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 103:5078-5083
33. Zhang X, Lian Z, Padden C, Gerstein MB, Rozowsky J, Snyder M et al (2009) A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. Blood 113:2526-2534
34. Valastyan S, Chang A, Benaich N, Reinhardt F, Weinberg RA (2010) Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. Cancer Res 70:5147-5154
35. Clape C, Fritz V, Henriquet C, Apparailly F, Fernandez PL, Iborra F et al (2009) miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS ONE 4:e7542
36. Shigoka M, Tsuchida A, Matsudo T, Nagakawa Y, Saito H, Suzuki Y et al (2010) Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol Int 60:351-357
37. Shinozaki A, Sakatani T, Ushiku T, Hino R, Isogai M, Ishikawa S et al (2010) Downregulation of microRNA-200 in EBV-associated gastric carcinoma. Cancer Res 70:4719-4727
38. Garzon R, Croce CM (2008) MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 15:352-358
39. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E et al (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 104:15805-15810
40. Mott JL, Kobayashi S, Bronk SF, Gores GJ (2007) mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26:6133-6140
41. Park SY, Lee JH, Ha M, Nam JW, Kim VN (2009) miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 16:23-29
42. Verrier JD, Lau P, Hudson L, Murashov AK, Renne R, Notterpek L (2010) Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a. Glia 57:1265-1279
43. Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V et al (2006) Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66:11590-11593
44. Zhao JJ, Lin J, Lwin T, Yang H, Guo J, Kong W et al (2010) microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 115:2630-2639
45. Kapinas K, Kessler CB, Ricks T, Gronowicz G, Delany AM (2010) miR-29 modulates WNT signaling in human osteoblasts through a positive feedback loop. J Biol Chem 285:25221-25231
46. Gebeshuber CA, Zatloukal K, Martinez J (2009) miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 10:400-405
47. Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA, Manjunath N (2007) miRNA profiling of na?ve, effector and memory CD8 T cells. PLoS ONE 2:e1020
48. Bellon M, Lepelletier Y, Hermine O, Nicot C (2009) Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood 113:4914-4917